The role and regulation of the peroxisome proliferator activated receptor alpha in human liver
- PMID: 28077274
- DOI: 10.1016/j.biochi.2016.12.019
The role and regulation of the peroxisome proliferator activated receptor alpha in human liver
Abstract
The peroxisome proliferator-activated receptor α (PPARα) is a ligand-activated transcription factor that is abundantly expressed in liver. PPARα is activated by fatty acids and various other lipid species, as well as by a class of chemicals referred to as peroxisome proliferators. Studies in mice have shown that PPARα serves as the master regulator of hepatic lipid metabolism during fasting. In addition, PPARα suppresses inflammation and the acute phase response. Comparatively little is known about PPARα in human liver. Here, an overview is provided of the role and regulation of PPARα in human liver. The main outcomes are: 1) the level of PPARA mRNA expression in human and mouse liver is similar. 2) Expression of PPARA in human liver is reduced in patients with non-alcoholic steatohepatitis or infected with the hepatitis C virus. 3) PPARα in human liver is able to effectively induce the expression of numerous genes involved in numerous lipid metabolic pathways, including microsomal, peroxisomal and mitochondrial fatty acid oxidation, fatty acid binding and activation, fatty acid elongation and desaturation, synthesis and breakdown of triglycerides and lipid droplets, lipoprotein metabolism, gluconeogenesis, bile acid metabolism, and various other metabolic pathways and genes. 4) PPARα activation in human liver causes the down-regulation of a large number of genes involved in various immunity-related pathways. 5) Peroxisome proliferators do not promote tumour formation in human liver as opposed to mouse liver because of structural and functional differences between human and mouse PPARα. 6) In addition to helping to correct dyslipidemia, PPARα agonists may hold promise as a therapy for patients with cholestatic liver diseases, non-alcoholic fatty liver disease, and/or type 2 diabetes.
Keywords: Human liver; Lipid metabolism; Non-alcoholic fatty liver disease; PPARα; Target genes.
Copyright © 2017 Elsevier B.V. and Société Française de Biochimie et Biologie Moléculaire (SFBBM). All rights reserved.
Similar articles
-
The impact of PPARα activation on whole genome gene expression in human precision cut liver slices.BMC Genomics. 2015 Oct 8;16:760. doi: 10.1186/s12864-015-1969-3. BMC Genomics. 2015. PMID: 26449539 Free PMC article.
-
PPARα/γ agonists and antagonists differently affect hepatic lipid metabolism, oxidative stress and inflammatory cytokine production in steatohepatitic rats.Cytokine. 2015 Sep;75(1):127-35. doi: 10.1016/j.cyto.2015.05.031. Epub 2015 Jul 17. Cytokine. 2015. PMID: 26194065
-
Molecular mechanism of PPARα action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease.J Hepatol. 2015 Mar;62(3):720-33. doi: 10.1016/j.jhep.2014.10.039. Epub 2014 Nov 1. J Hepatol. 2015. PMID: 25450203 Review.
-
PPARα/HNF4α interplay on diversified responsive elements. Relevance in the regulation of liver peroxisomal fatty acid catabolism.Curr Drug Metab. 2012 Dec;13(10):1436-53. doi: 10.2174/138920012803762738. Curr Drug Metab. 2012. PMID: 22978398 Review.
-
Differential regulation of peroxisome proliferator-activated receptor (PPAR)-alpha1 and truncated PPARalpha2 as an adaptive response to fasting in the control of hepatic peroxisomal fatty acid beta-oxidation in the hibernating mammal.Endocrinology. 2009 Mar;150(3):1192-201. doi: 10.1210/en.2008-1394. Epub 2008 Oct 23. Endocrinology. 2009. PMID: 18948393
Cited by
-
Spatially resolved analysis of microenvironmental gradient impact on cancer cell phenotypes.Sci Adv. 2024 May 3;10(18):eadn3448. doi: 10.1126/sciadv.adn3448. Epub 2024 May 3. Sci Adv. 2024. PMID: 38701211 Free PMC article.
-
Calorie Restriction Using High-Fat/Low-Carbohydrate Diet Suppresses Liver Fat Accumulation and Pancreatic Beta-Cell Dedifferentiation in Obese Diabetic Mice.Nutrients. 2024 Mar 28;16(7):995. doi: 10.3390/nu16070995. Nutrients. 2024. PMID: 38613031 Free PMC article.
-
Dihydromyricetin ameliorates hepatic steatosis and insulin resistance via AMPK/PGC-1α and PPARα-mediated autophagy pathway.J Transl Med. 2024 Mar 26;22(1):309. doi: 10.1186/s12967-024-05060-7. J Transl Med. 2024. PMID: 38532480 Free PMC article.
-
Evaluation of the hepatotoxicity of Psoralea corylifolia L. based on a zebrafish model.Front Pharmacol. 2024 Feb 21;15:1308655. doi: 10.3389/fphar.2024.1308655. eCollection 2024. Front Pharmacol. 2024. PMID: 38449808 Free PMC article.
-
Association between dietary macronutrient composition and plasma one-carbon metabolites and B-vitamin cofactors in patients with stable angina pectoris.Br J Nutr. 2024 May 28;131(10):1678-1690. doi: 10.1017/S0007114524000473. Epub 2024 Feb 16. Br J Nutr. 2024. PMID: 38361451 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources